The United States has announced a trade agreement with the United Kingdom that eliminates tariffs on pharmaceutical products and medical technologies. In return, the United Kingdom will increase the percentage of the NHS budget allocated to medications and will pay 25% more for new drugs. The agreement aims to stimulate investment and innovation in both countries, according to U.S. Trade Representative Jamieson Greer. A change in the assessment of therapy value by NICE is also expected, which will modify the threshold used to determine the effectiveness of medications. The U.S. has pressured the UK to pay more for American drugs, and the pharmaceutical industry has expressed dissatisfaction with the conditions in the United Kingdom. London has committed to reducing the reimbursement rate to 15% starting in 2026.
Sources
Latest News
23:00
London authorities close traffic on Oxford Street: Britain’s busiest shopping street becomes pedestrian-only
22:55
Meta seeks to raise up to $95 billion to expand its artificial intelligence infrastructure
22:47
Audi CEO criticized in Germany after appearing alongside Trump / Gernot Döllner participated in the announcement of a $4.2 billion investment to build Audi’s first factory in the US
22:39
Kelemen Hunor estimates that the Luca Niculescu Government will remain in power until 2028: “If nobody brings you down, then you have no choice, you are condemned to govern”
22:33
Microsoft offers voluntary departures to approximately 60,000 employees across four countries amid massive investments in artificial intelligence
See more news